FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 345:1291-1297 November 1, 2001 Number 18 Next

	Full Text PDF Editorial by Panza, J. A. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Information is limited regarding the risk of cardiovascular disease in persons with high-normal blood pressure (systolic pressure of 130 to 139 mm Hg, diastolic pressure of 85 to 89 mm Hg, or both).

Methods We investigated the association between blood-pressure category at base line and the incidence of cardiovascular disease on follow-up among 6859 participants in the Framingham Heart Study who were initially free of hypertension and cardiovascular disease.

Results A stepwise increase in cardiovascular event rates was noted in persons with higher base-line blood-pressure categories. The 10-year cumulative incidence of cardiovascular disease in subjects 35 to 64 years of age who had high-normal blood pressure was 4 percent (95 percent confidence interval, 2 to 5 percent) for women and 8 percent (95 percent confidence interval, 6 to 10 percent) for men; in older subjects (those 65 to 90 years old), the incidence was 18 percent (95 percent confidence interval, 12 to 23 percent) for women and 25 percent (95 percent confidence interval, 17 to 34 percent) for men. As compared with optimal blood pressure, high-normal blood pressure was associated with a risk-factor–adjusted hazard ratio for cardiovascular disease of 2.5 (95 percent confidence interval, 1.6 to 4.1) in women and 1.6 (95 percent confidence interval, 1.1 to 2.2) in men.

Conclusions High-normal blood pressure is associated with an increased risk of cardiovascular disease. Our findings emphasize the need to determine whether lowering high-normal blood pressure can reduce the risk of cardiovascular disease.

Source Information

From the Framingham Heart Study, Framingham, Mass. (R.S.V., M.G.L., E.P.L., J.C.E., C.J.O., D.L.); the Cardiology Section (R.S.V.) and the Department of Preventive Medicine and Epidemiology (R.S.V., M.G.L., J.C.E., W.B.K., D.L.), Boston University School of Medicine, Boston; the Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston (C.J.O.); the Divisions of Cardiology and Clinical Epidemiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston (D.L.); and the National Heart, Lung, and Blood Institute, Bethesda, Md. (C.J.O., D.L.).

Address reprint requests to Dr. Vasan at the Framingham Heart Study, 5 Thurber St., Framingham, MA 01702, or at vasan{at}fram.nhlbi.nih.gov.

Full Text of this Article

This article has been cited by other articles:

• Britton, K. A., Gaziano, J. M., Djousse, L. (2009). Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail 11: 1129-1134 [Abstract] [Full Text]  
• Bohm, M., Mahfoud, F., Werner, C., Teo, K., Baumhakel, M. (2009). Cardiovascular protection: a breakthrough for high-risk patients. Eur Heart J Suppl 11: F19-F26 [Abstract] [Full Text]  
• Ong, H. T. (2009). Are Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Especially Useful for Cardiovascular Protection?. J Am Board Fam Med 22: 686-697 [Abstract] [Full Text]  
• Leibowitz, A., Grossman, E. (2009). How to Define Prehypertension in Diabetes/Metabolic Syndrome. Diabetes Care 32: S275-S279 [Full Text]  
• Grossman, E. (2009). Should We Treat Prehypertension in Diabetes?: What are the cons?. Diabetes Care 32: S280-S283 [Full Text]  
• Segura, J., Ruilope, L. M. (2009). Treatment of Prehypertension in Diabetes and Metabolic Syndrome: What are the pros?. Diabetes Care 32: S284-S289 [Full Text]  
• De Marco, M., de Simone, G., Roman, M. J., Chinali, M., Lee, E. T., Russell, M., Howard, B. V., Devereux, R. B. (2009). Cardiovascular and Metabolic Predictors of Progression of Prehypertension Into Hypertension: The Strong Heart Study. Hypertension 54: 974-980 [Abstract] [Full Text]  
• Glasser, S. P., Basile, J. N., Lackland, D. T. (2009). Does Prehypertension Represent an Increased Risk for Incident Hypertension and Adverse Cardiovascular Outcome?. Hypertension 54: 954-955 [Full Text]  
• Lucini, D., Zuccotti, G., Malacarne, M., Scaramuzza, A., Riboni, S., Palombo, C., Pagani, M. (2009). Early Progression of the Autonomic Dysfunction Observed in Pediatric Type 1 Diabetes Mellitus. Hypertension 54: 987-994 [Abstract] [Full Text]  
• Ataei, N., Hosseini, M., Iranmanesh, M. (2009). The Relationship of Body Mass Index and Blood Pressure in Iranian Children <7 Years Old. J Trop Pediatr 55: 313-317 [Abstract] [Full Text]  
• Mullican, D. R., Lorenzo, C., Haffner, S. M. (2009). Is Prehypertension a Risk Factor for the Development of Type 2 Diabetes?. Diabetes Care 32: 1870-1872 [Abstract] [Full Text]  
• Cohen, D. L., Bloedon, L. T., Rothman, R. L., Farrar, J. T., Galantino, M. L., Volger, S., Mayor, C., Szapary, P. O., Townsend, R. R. (2009). Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial. Evid Based Complement Alternat Med 0: nep130v1-nep130 [Abstract] [Full Text]  
• Flint, A. J, Hu, F. B, Glynn, R. J, Jensen, M. K, Franz, M., Sampson, L., Rimm, E. B (2009). Whole grains and incident hypertension in men. Am. J. Clin. Nutr. 90: 493-498 [Abstract] [Full Text]  
• Pressman, S. D., Matthews, K. A., Cohen, S., Martire, L. M., Scheier, M., Baum, A., Schulz, R. (2009). Association of Enjoyable Leisure Activities With Psychological and Physical Well-Being. Psychosom. Med. 71: 725-732 [Abstract] [Full Text]  
• Kivimaki, M., Batty, G. D., Singh-Manoux, A., Ferrie, J. E., Tabak, A. G., Jokela, M., Marmot, M. G., Smith, G. D., Shipley, M. J. (2009). Validating the Framingham Hypertension Risk Score: Results From the Whitehall II Study. Hypertension 54: 496-501 [Abstract] [Full Text]  
• Rubinstein, A., Alcocer, L., Chagas, A. (2009). High blood pressure in Latin America: a call to action. Ther Adv Cardiovasc Dis 3: 259-285 [Abstract]  
• Houlihan, S. J., Simpson, S. H., Cave, A. J., Flook, N. W., Hurlburt, M. E., Lord, C. J., Smith, L. L., Sternberg, H. H. (2009). Hypertension treatment and control rates: Chart review in an academic family medicine clinic. cfp 55: 735-741 [Abstract] [Full Text]  
• Barton, M., Meyer, M. R. (2009). Postmenopausal Hypertension: Mechanisms and Therapy. Hypertension 54: 11-18 [Full Text]  
• Plantinga, L. C., Miller, E. R. III, Stevens, L. A., Saran, R., Messer, K., Flowers, N., Geiss, L., Powe, N. R., for the Centers for Disease Control and Prevention, (2009). Blood Pressure Control Among Persons Without and With Chronic Kidney Disease: US Trends and Risk Factors 1999-2006. Hypertension 54: 47-56 [Abstract] [Full Text]  
• Su, K.-H., Tsai, J.-Y., Kou, Y. R., Chiang, A.-N., Hsiao, S.-H., Wu, Y.-L., Hou, H.-H., Pan, C.-C., Shyue, S.-K., Lee, T.-S. (2009). Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling. Cardiovasc Res 82: 468-475 [Abstract] [Full Text]  
• Mogelvang, R., Sogaard, P., Pedersen, S. A., Olsen, N. T., Schnohr, P., Jensen, J. S. (2009). Tissue Doppler echocardiography in persons with hypertension, diabetes, or ischaemic heart disease: the Copenhagen City Heart Study. Eur Heart J 30: 731-739 [Abstract] [Full Text]  
• Roghair, R. D., Segar, J. L., Volk, K. A., Chapleau, M. W., Dallas, L. M., Sorenson, A. R., Scholz, T. D., Lamb, F. S. (2009). Vascular nitric oxide and superoxide anion contribute to sex-specific programmed cardiovascular physiology in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R651-R662 [Abstract] [Full Text]  
• Duda, M. K., O'Shea, K. M., Tintinu, A., Xu, W., Khairallah, R. J., Barrows, B. R., Chess, D. J., Azimzadeh, A. M., Harris, W. S., Sharov, V. G., Sabbah, H. N., Stanley, W. C. (2009). Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 81: 319-327 [Abstract] [Full Text]  
• Ibrahim, H. N., Foley, R., Tan, L., Rogers, T., Bailey, R. F., Guo, H., Gross, C. R., Matas, A. J. (2009). Long-Term Consequences of Kidney Donation. NEJM 360: 459-469 [Abstract] [Full Text]  
• Trivedi, H., Xiang, Q., Klein, J. P. (2009). Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Nephrol Dial Transplant 24: 258-266 [Abstract] [Full Text]  
• Rosengren, A., Perk, J., Dallongeville, J. (2009). CHAPTER 12 Prevention of Cardiovascular Disease. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Kannel, W. B., Wolf, P. A. (2008). Framingham Study Insights on the Hazards of Elevated Blood Pressure. JAMA 300: 2545-2547 [Full Text]  
• Smoley, B. A., Smith, N. L., Runkle, G. P. (2008). Hypertension in a Population of Active Duty Service Members. J Am Board Fam Med 21: 504-511 [Abstract] [Full Text]  
• Rohatagi, S., Lee, J., Shenouda, M., Haworth, S., Bathala, M. S., Allison, M., Rubets, I., Heyrman, R., Noveck, R., Salazar, D. E. (2008). Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed-Dose Combination. J Clin Pharmacol 48: 1309-1322 [Abstract] [Full Text]  
• Godwin, M., Pike, A., Kirby, A., Jewer, C., Murphy, L. (2008). Prehypertension and hypertension in a primary care practice. cfp 54: 1418-1423 [Abstract] [Full Text]  
• Papanikolaou, Y., Fulgoni, V. L. III (2008). Bean Consumption Is Associated with Greater Nutrient Intake, Reduced Systolic Blood Pressure, Lower Body Weight, and a Smaller Waist Circumference in Adults: Results from the National Health and Nutrition Examination Survey 1999-2002. J. Am. Coll. Nutr. 27: 569-576 [Abstract] [Full Text]  
• Kokubo, Y., Kamide, K., Okamura, T., Watanabe, M., Higashiyama, A., Kawanishi, K., Okayama, A., Kawano, Y. (2008). Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease in a Japanese Urban Cohort: The Suita Study. Hypertension 52: 652-659 [Abstract] [Full Text]  
• Romero, J. R., Morris, J., Pikula, A. (2008). Review: Stroke prevention: modifying risk factors. Ther Adv Cardiovasc Dis 2: 287-303 [Abstract]  
• Egan, B. M., Nesbitt, S. D., Julius, S. (2008). Review: Prehypertension: should we be treating with pharmacologic therapy?. Ther Adv Cardiovasc Dis 2: 305-314 [Abstract]  
• Pletcher, M. J., Bibbins-Domingo, K., Lewis, C. E., Wei, G. S., Sidney, S., Carr, J. J., Vittinghoff, E., McCulloch, C. E., Hulley, S. B. (2008). Prehypertension during Young Adulthood and Coronary Calcium Later in Life. ANN INTERN MED 149: 91-99 [Abstract] [Full Text]  
• Phillips, L. S., Twombly, J. G. (2008). It's Time to Overcome Clinical Inertia. ANN INTERN MED 148: 783-785 [Full Text]  
• Genovesi, S., Pieruzzi, F., Giussani, M., Tono, V., Stella, A., Porta, A., Pagani, M., Lucini, D. (2008). Analysis of Heart Period and Arterial Pressure Variability in Childhood Hypertension: Key Role of Baroreflex Impairment. Hypertension 51: 1289-1294 [Abstract] [Full Text]  
• Cheng, C., Daskalakis, C., Falkner, B. (2008). Original Research: Capillary rarefaction in treated and untreated hypertensive subjects. Ther Adv Cardiovasc Dis 2: 79-88 [Abstract]  
• Wyatt, S. B., Akylbekova, E. L., Wofford, M. R., Coady, S. A., Walker, E. R., Andrew, M. E., Keahey, W. J., Taylor, H. A., Jones, D. W. (2008). Prevalence, Awareness, Treatment, and Control of Hypertension in the Jackson Heart Study. Hypertension 51: 650-656 [Abstract] [Full Text]  
• Knecht, S., Wersching, H., Lohmann, H., Bruchmann, M., Duning, T., Dziewas, R., Berger, K., Ringelstein, E. B. (2008). High-Normal Blood Pressure Is Associated With Poor Cognitive Performance. Hypertension 51: 663-668 [Abstract] [Full Text]  
• Sironi, A. M., Pingitore, A., Ghione, S., De Marchi, D., Scattini, B., Positano, V., Muscelli, E., Ciociaro, D., Lombardi, M., Ferrannini, E., Gastaldelli, A. (2008). Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat. Hypertension 51: 282-288 [Abstract] [Full Text]  
• Geller, J. C., Cassens, S., Brosz, M., Keil, U., Bernarding, J., Kropf, S., Bierwirth, R. A., Lippmann-Grob, B., Schultheiss, H.-P., Schluter, K., Pels, K. (2007). Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. Eur Heart J 28: 3051-3058 [Abstract] [Full Text]  
• Player, M. S., King, D. E., Mainous, A. G. III, Geesey, M. E. (2007). Psychosocial Factors and Progression From Prehypertension to Hypertension or Coronary Heart Disease. Ann Fam Med 5: 403-411 [Abstract] [Full Text]  
• Conen, D., Ridker, P. M, Buring, J. E, Glynn, R. J (2007). Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 335: 432-432 [Abstract] [Full Text]  
• Chobanian, A. V. (2007). Isolated Systolic Hypertension in the Elderly. NEJM 357: 789-796 [Full Text]  
• Collins, P., Rosano, G., Casey, C., Daly, C., Gambacciani, M., Hadji, P., Kaaja, R., Mikkola, T., Palacios, S., Preston, R., Simon, T., Stevenson, J., Stramba-Badiale, M. (2007). Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 28: 2028-2040 [Abstract] [Full Text]  
• Taylor, E. N., Forman, J. P., Farwell, W. R. (2007). Serum Anion Gap and Blood Pressure in the National Health and Nutrition Examination Survey. Hypertension 50: 320-324 [Abstract] [Full Text]  
• Ninomiya, T., Kubo, M., Doi, Y., Yonemoto, K., Tanizaki, Y., Tsuruya, K., Sueishi, K., Tsuneyoshi, M., Iida, M., Kiyohara, Y. (2007). Prehypertension Increases the Risk for Renal Arteriosclerosis in Autopsies: The Hisayama Study. J. Am. Soc. Nephrol. 18: 2135-2142 [Abstract] [Full Text]  
• Authors/Task Force Members:, , Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A.J., Zanchetti, A., ESC Committee for Practice Guidelines (CPG):, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., ESH Scientific Council:, , Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., Fagard, R., Heagerty, A. M., Laurent, S., Lindholm, L. H., Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.J., Viigimaa, M., Document Reviewers:, , Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M., Manolis, A. J., Nilsson, P. M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., Zamorano, J. L. (2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 0: ehm236v1-75 [Full Text]  
• Wexler, R. K. (2007). Treatment of Hypertension Critical in Reducing Morbidity and Mortality. J Am Board Fam Med 20: 322-322 [Full Text]  
• Cook, N. R, Cutler, J. A, Obarzanek, E., Buring, J. E, Rexrode, K. M, Kumanyika, S. K, Appel, L. J, Whelton, P. K (2007). Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 334: 885-885 [Abstract] [Full Text]  
• Kikuya, M., Hansen, T. W., Thijs, L., Bjorklund-Bodegard, K., Kuznetsova, T., Ohkubo, T., Richart, T., Torp-Pedersen, C., Lind, L., Ibsen, H., Imai, Y., Staessen, J. A., on behalf of the International Database on Ambulat, (2007). Diagnostic Thresholds for Ambulatory Blood Pressure Monitoring Based on 10-Year Cardiovascular Risk. Circulation 115: 2145-2152 [Abstract] [Full Text]  
• Redon, J., Cea-Calvo, L., Lozano, J. V., Marti-Canales, J. C., Llisterri, J. L., Aznar, J., Gonzalez-Esteban, J., on behalf of the investigators of the PREV-ICTUS s, (2007). Blood Pressure and Estimated Risk of Stroke in the Elderly Population of Spain: The PREV-ICTUS Study. Stroke 38: 1167-1173 [Abstract] [Full Text]  
• Deepak, D, Furlong, N J, Wilding, J P H, MacFarlane, I A (2007). Cardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease. Postgrad. Med. J. 83: 277-280 [Abstract] [Full Text]  
• Nawrot, T. S., Staessen, J. A., Roels, H. A., Den Hond, E., Thijs, L., Fagard, R. H., Dominiczak, A. F., Struijker-Boudier, H. A. (2007). Blood pressure and blood selenium: a cross-sectional and longitudinal population study. Eur Heart J 28: 628-633 [Abstract] [Full Text]  
• Hsia, J., Margolis, K. L., Eaton, C. B., Wenger, N. K., Allison, M., Wu, L., LaCroix, A. Z., Black, H. R., for the Women's Health Initiative Investigators, (2007). Prehypertension and Cardiovascular Disease Risk in the Women's Health Initiative. Circulation 115: 855-860 [Abstract] [Full Text]  
• Erdogan, D., Yildirim, I., Ciftci, O., Ozer, I., Caliskan, M., Gullu, H., Muderrisoglu, H. (2007). Effects of Normal Blood Pressure, Prehypertension, and Hypertension on Coronary Microvascular Function. Circulation 115: 593-599 [Abstract] [Full Text]  
• Opie, L. H. (2007). Metabolic Syndrome. Circulation 115: e32-e35 [Full Text]  
• Drukteinis, J. S., Roman, M. J., Fabsitz, R. R., Lee, E. T., Best, L. G., Russell, M., Devereux, R. B. (2007). Cardiac and Systemic Hemodynamic Characteristics of Hypertension and Prehypertension in Adolescents and Young Adults: The Strong Heart Study. Circulation 115: 221-227 [Abstract] [Full Text]  
• Weir, M. R. (2007). How Do You Define "Hypertension" in a Patient With Type 1 Diabetes?. Hypertension 49: 13-14 [Full Text]  
• Kistler, P. M., Sanders, P., Dodic, M., Spence, S. J., Samuel, C. S., Zhao, C., Charles, J. A., Edwards, G. A., Kalman, J. M. (2006). Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 27: 3045-3056 [Abstract] [Full Text]  
• Okere, I. C., Young, M. E., McElfresh, T. A., Chess, D. J., Sharov, V. G., Sabbah, H. N., Hoit, B. D., Ernsberger, P., Chandler, M. P., Stanley, W. C. (2006). Low Carbohydrate/High-Fat Diet Attenuates Cardiac Hypertrophy, Remodeling, and Altered Gene Expression in Hypertension. Hypertension 48: 1116-1123 [Abstract] [Full Text]  
• Chobanian, A. V. (2006). Prehypertension Revisited. Hypertension 48: 812-814 [Full Text]  
• Ingelsson, E, Arnlov, J, Lind, L, Sundstrom, J (2006). Metabolic syndrome and risk for heart failure in middle-aged men. Heart 92: 1409-1413 [Abstract] [Full Text]  
• Grotto, I., Grossman, E., Huerta, M., Sharabi, Y. (2006). Prevalence of Prehypertension and Associated Cardiovascular Risk Profiles Among Young Israeli Adults. Hypertension 48: 254-259 [Abstract] [Full Text]  
• White, W. B., Hanes, V., Chauhan, V., Pitt, B. (2006). Effects of a New Hormone Therapy, Drospirenone and 17-{beta}-Estradiol, in Postmenopausal Women With Hypertension. Hypertension 48: 246-253 [Abstract] [Full Text]  
• Stang, A., Moebus, S., Mohlenkamp, S., Dragano, N., Schmermund, A., Beck, E.-M., Siegrist, J., Erbel, R., Jockel, K.-H., on behalf of the Heinz Nixdorf Recall Study Invest, (2006). Algorithms for Converting Random-Zero to Automated Oscillometric Blood Pressure Values, and Vice Versa. Am J Epidemiol 164: 85-94 [Abstract] [Full Text]  
• Ommen, E. S., Winston, J. A., Murphy, B. (2006). Medical Risks in Living Kidney Donors: Absence of Proof Is Not Proof of Absence. CJASN 1: 885-895 [Abstract] [Full Text]  
• Srinivasan, S. R., Myers, L., Berenson, G. S. (2006). Changes in Metabolic Syndrome Variables Since Childhood in Prehypertensive and Hypertensive Subjects: The Bogalusa Heart Study. Hypertension 48: 33-39 [Abstract] [Full Text]  
• Zillich, A. J., Haines, S. T. (2006). ASHP Therapeutic Position Statement on the Treatment of Hypertension.. Am J Health Syst Pharm 63: 1074-1080 [Full Text]  
• Poulter, N. (2006). Are current therapies for hypertension achieving their goal?. Journal of Renin-Angiotensin-Aldosterone System 7: S3-S6 [Abstract]  
• Pearte, C. A., Furberg, C. D., O'Meara, E. S., Psaty, B. M., Kuller, L., Powe, N. R., Manolio, T. (2006). Characteristics and Baseline Clinical Predictors of Future Fatal Versus Nonfatal Coronary Heart Disease Events in Older Adults: The Cardiovascular Health Study. Circulation 113: 2177-2185 [Abstract] [Full Text]  
• Kovesdy, C. P., Trivedi, B. K., Kalantar-Zadeh, K., Anderson, J. E. (2006). Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant 21: 1257-1262 [Abstract] [Full Text]  
• Lee, J. E., Kim, Y.-G., Choi, Y.-H., Huh, W., Kim, D. J., Oh, H. Y. (2006). Serum Uric Acid Is Associated With Microalbuminuria in Prehypertension. Hypertension 47: 962-967 [Abstract] [Full Text]  
• Schunkert, H. (2006). Pharmacotherapy for Prehypertension -- Mission Accomplished?. NEJM 354: 1742-1744 [Full Text]  
• Julius, S., Nesbitt, S. D., Egan, B. M., Weber, M. A., Michelson, E. L., Kaciroti, N., Black, H. R., Grimm, R. H. Jr., Messerli, F. H., Oparil, S., Schork, M. A., the Trial of Preventing Hypertension (TROPHY) Stud, (2006). Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker. NEJM 354: 1685-1697 [Abstract] [Full Text]  
• Elmer, P. J., Obarzanek, E., Vollmer, W. M., Simons-Morton, D., Stevens, V. J., Young, D. R., Lin, P.-H., Champagne, C., Harsha, D. W., Svetkey, L. P., Ard, J., Brantley, P. J., Proschan, M. A., Erlinger, T. P., Appel, L. J., for the PREMIER Collaborative Research Group, (2006). Effects of Comprehensive Lifestyle Modification on Diet, Weight, Physical Fitness, and Blood Pressure Control: 18-Month Results of a Randomized Trial. ANN INTERN MED 144: 485-495 [Abstract] [Full Text]  
• Wang, W., Lee, E. T., Fabsitz, R. R., Devereux, R., Best, L., Welty, T. K., Howard, B. V. (2006). A Longitudinal Study of Hypertension Risk Factors and Their Relation to Cardiovascular Disease: The Strong Heart Study. Hypertension 47: 403-409 [Abstract] [Full Text]  
• Appel, L. J., Brands, M. W., Daniels, S. R., Karanja, N., Elmer, P. J., Sacks, F. M. (2006). Dietary Approaches to Prevent and Treat Hypertension: A Scientific Statement From the American Heart Association. Hypertension 47: 296-308 [Abstract] [Full Text]  
• Tomiyama, H., Hashimoto, H., Hirayama, Y., Yambe, M., Yamada, J., Koji, Y., Shiina, K., Yamamoto, Y., Yamashina, A. (2006). Synergistic Acceleration of Arterial Stiffening in the Presence of Raised Blood Pressure and Raised Plasma Glucose. Hypertension 47: 180-188 [Abstract] [Full Text]  
• Barlow, C. E., LaMonte, M. J., FitzGerald, S. J., Kampert, J. B., Perrin, J. L., Blair, S. N. (2006). Cardiorespiratory Fitness Is an Independent Predictor of Hypertension Incidence among Initially Normotensive Healthy Women. Am J Epidemiol 163: 142-150 [Abstract] [Full Text]  
• Prepared by: British Cardiac Society, British Hype, (2005). JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 91: v1-v52 [Full Text]  
• Lucini, D., Di Fede, G., Parati, G., Pagani, M. (2005). Impact of Chronic Psychosocial Stress on Autonomic Cardiovascular Regulation in Otherwise Healthy Subjects. Hypertension 46: 1201-1206 [Abstract] [Full Text]  
• Asayama, K., Ohkubo, T., Kikuya, M., Metoki, H., Obara, T., Hoshi, H., Hashimoto, J., Totsune, K., Satoh, H., Imai, Y. (2005). Use of 2003 European Society of Hypertension-European Society of Cardiology guidelines for predicting stroke using self-measured blood pressure at home: the Ohasama study. Eur Heart J 26: 2026-2031 [Abstract] [Full Text]  
• Lloyd-Jones, D. M., Sutton-Tyrrell, K., Patel, A. S., Matthews, K. A., Pasternak, R. C., Everson-Rose, S. A., Scuteri, A., Chae, C. U. (2005). Ethnic Variation in Hypertension Among Premenopausal and Perimenopausal Women: Study of Women's Health Across the Nation. Hypertension 46: 689-695 [Abstract] [Full Text]  
• Abuissa, H., Jones, P. G., Marso, S. P., O'Keefe, J. H. Jr (2005). Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials. J Am Coll Cardiol 46: 821-826 [Abstract] [Full Text]